Factores que influyen en la demora del tratamiento fibrinolítico en el ictus isquémico

Palomino García, Alfredo; Moniche Álvarez, Francisco; Torre Laviana, Francisco J de la; Cayuela Domínguez, Aurelio; Vigil, Eduardo; Jiménez Hérnández, M. Dolores.
Rev. neurol. (Ed. impr.) ; 51(12): 714-720, 16 dic., 2010. tab
Artículo en Español | IBECS (España) | ID: ibc-86931

Documentos relacionados

  1. Effect of Chandler loop shear and tubing size on thrombus architecture.
  2. Regionalization of stroke systems of care in the stroke belt states: The IMPROVE stroke care quality improvement program.
  3. Deciphering the contextual barriers to mainstreaming the implementation of stroke thrombolysis in a Ghanaian hospital: Findings from the activate mixed-methods study.
  4. APPLICATION OF THROMBOLYSIS THERAPY FOR ACUTE CEREBRAL CIRCULATION IN THE REPUBLIC OF KAZAKHSTAN, COUNTRIES OF THE FAR AND NEAR FOREIGN COUNTRIES.
  5. In ischemic stroke with viable hypoperfused tissue, alteplase > 4.5 h after last seen well improves function.
  6. External quality monitoring facilitates improvement in already well-performing stroke units: insights from RES-Q Poland.
  7. Prehospital Stroke Triage: A Modeling Study on the Impact of Triage Tools in Different Regions.
  8. Telemedicine for Acute Monocular Visual Loss: A Retrospective Large Telestroke Network Experience.
  9. Determinants and Trends of the Use of Intravenous Thrombolysis for Minor Stroke: A Population-Based Study, 2016 to 2020.
  10. Advances in Recurrent Stroke Prevention: Focus on Antithrombotic Therapies.